{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:13:30Z","timestamp":1792725210222,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003659"],"award-info":[{"award-number":["82003659"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073385"],"award-info":[{"award-number":["82073385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172706"],"award-info":[{"award-number":["82172706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20DZ2255200"],"award-info":[{"award-number":["20DZ2255200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22S21902700"],"award-info":[{"award-number":["22S21902700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23S21900800"],"award-info":[{"award-number":["23S21900800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jconrel.2023.12.009","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:00:40Z","timestamp":1702666840000},"page":"818-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Transdermal delivery of Fn14 siRNA using a novel composite ionic liquid for treatment of psoriasis-like skin lesions"],"prefix":"10.1016","volume":"365","author":[{"given":"Lisha","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengze","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongguang","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2023.12.009_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41423-020-0519-3","article-title":"\"autoinflammatory psoriasis\"-genetics and biology of pustular psoriasis","volume":"18","author":"Uppala","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"9583","key":"10.1016\/j.jconrel.2023.12.009_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jconrel.2023.12.009_bb0015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/annrheumdis-2018-214065","article-title":"Prevalence and incidence of psoriasis and psoriatic arthritis","volume":"78","author":"Sewerin","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2023.12.009_bb0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamadermatol.2020.0024","article-title":"Prevalence, incidence, and risk of Cancer in patients with psoriasis and psoriatic arthritis: a systematic review and Meta-analysis","volume":"156","author":"Vaengebjerg","year":"2020","journal-title":"JAMA Dermatol."},{"issue":"3","key":"10.1016\/j.jconrel.2023.12.009_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2023.12.009_bb0030","doi-asserted-by":"crossref","first-page":"102916","DOI":"10.1016\/j.jaut.2022.102916","article-title":"Pathogenesis, multi-omics research, and clinical treatment of psoriasis","volume":"133","author":"Yu","year":"2022","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.jconrel.2023.12.009_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/joim.13282","article-title":"Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach","volume":"290","author":"Hedin","year":"2021","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2023.12.009_bb0040","doi-asserted-by":"crossref","DOI":"10.7326\/AITC201804030","article-title":"Psoriasis","volume":"168","author":"Lebwohl","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaad.2022.01.005","article-title":"A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis","volume":"87","author":"Zhang","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaad.2021.08.066","article-title":"A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results","volume":"86","author":"Magnolo","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10378","key":"10.1016\/j.jconrel.2023.12.009_bb0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/JCI130740","article-title":"Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis","volume":"131","author":"Chen","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.jconrel.2023.12.009_bb0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41419-018-0820-6","article-title":"Fn14 deficiency ameliorates psoriasis-like skin disease in a murine model","volume":"9","author":"Peng","year":"2018","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.jconrel.2023.12.009_bb0070","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jaci.2020.12.657","article-title":"Cross-talk between IFN-gamma and TWEAK through miR-149 amplifies skin inflammation in psoriasis","volume":"147","author":"Srivastava","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2023.12.009_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrd2488","article-title":"The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting","volume":"7","author":"Winkles","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jconrel.2023.12.009_bb0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11154-021-09688-4","article-title":"The TWEAK\/Fn14\/CD163 axis-implications for metabolic disease","volume":"23","author":"Ratajczak","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"65","key":"10.1016\/j.jconrel.2023.12.009_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi8823","article-title":"TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy","volume":"6","author":"Gupta","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2023.12.009_bb0090","doi-asserted-by":"crossref","first-page":"15395","DOI":"10.1038\/ncomms15395","article-title":"TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis","volume":"8","author":"Sidler","year":"2017","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jconrel.2023.12.009_bb0095","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s12276-023-00998-y","article-title":"Where should siRNAs go: applicable organs for siRNA drugs","volume":"55","author":"Ahn","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2023.12.009_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2020.04.038","article-title":"Topical delivery of siRNA into skin using ionic liquids","volume":"323","author":"Dharamdasani","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.009_bb0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2021.08.039","article-title":"TNFalpha siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy","volume":"338","author":"Suzuki","year":"2021","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2023.12.009_bb0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","article-title":"Therapeutic siRNA: state-of-the-art and future perspectives","volume":"36","author":"Friedrich","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.jconrel.2023.12.009_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.009_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2021.12.030","article-title":"Evolution of drug delivery systems: from 1950 to 2020 and beyond","volume":"342","author":"Park","year":"2022","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2023.12.009_bb0125","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s13346-022-01138-1","article-title":"Transdermal delivery for gene therapy","volume":"12","author":"Singh","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2023.12.009_bb0130","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1021\/acs.chemrev.6b00562","article-title":"Biological activity of ionic liquids and their application in pharmaceutics and medicine","volume":"117","author":"Egorova","year":"2017","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2023.12.009_bb0135","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1039\/c2cs15311d","article-title":"Ionic liquid processing of cellulose","volume":"41","author":"Wang","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2023.12.009_bb0140","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","article-title":"Oral delivery of proteins and peptides: challenges, status quo and future perspectives","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"Pt A","key":"10.1016\/j.jconrel.2023.12.009_bb0145","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijbiomac.2022.04.050","article-title":"Insights into protein-ionic liquid interaction: a comprehensive overview on theoretical and experimental approaches","volume":"209","author":"Tarannum","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2023.12.009_bb0150","doi-asserted-by":"crossref","first-page":"108055","DOI":"10.1016\/j.biotechadv.2022.108055","article-title":"Ionic liquids as protein stabilizers for biological and biomedical applications: a review","volume":"61","author":"Verissimo","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2023.12.009_bb0155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijbiomac.2020.02.072","article-title":"Improving dermal delivery of hyaluronic acid by ionic liquids for attenuating skin dehydration","volume":"150","author":"Wu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/ard.2008.090548","article-title":"TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade","volume":"69","author":"van Kuijk","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0165","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1038\/s41467-023-39484-4","article-title":"Differentiation of IL-26(+) T(H)17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis","volume":"14","author":"Fries","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0170","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1038\/s41598-023-39218-y","article-title":"Sericin coated thin polymeric films reduce keratinocyte proliferation via the mTOR pathway and epidermal inflammation through IL17 signaling in psoriasis rat model","volume":"13","author":"Aramwit","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0175","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/s41467-021-25066-9","article-title":"Enhanced NF-kappaB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis","volume":"12","author":"Andres-Ejarque","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjd.19380","article-title":"Role of regulatory T cells in psoriasis pathogenesis and treatment","volume":"184","author":"Nussbaum","year":"2021","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0185","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1038\/s41598-023-37010-6","article-title":"Anti-TNF-alpha therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data","volume":"13","author":"Joulfayan","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2023.12.009_bb0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41467-017-02466-4","article-title":"TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis","volume":"9","author":"Conrad","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2023.12.009_bb0195","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s12276-021-00620-z","article-title":"2'-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice","volume":"53","author":"Hao","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.jconrel.2023.12.009_bb0200","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.it.2021.09.005","article-title":"RORgammat protein modifications and IL-17-mediated inflammation","volume":"42","author":"Kumar","year":"2021","journal-title":"Trends Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923007939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923007939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:56:33Z","timestamp":1759164993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923007939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"alternative-id":["S0168365923007939"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.009","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal delivery of Fn14 siRNA using a novel composite ionic liquid for treatment of psoriasis-like skin lesions","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}